Dual-task training protocol aims to answer a long-standing Parkinson’s question
In Parkinson’s disease, the problem is not only slower movement. It is the breakdown of automatic movement under cognitive pressure, when walking, balancing, or handling a daily task must compete for the same limited attentional resources. This PLOS ONE protocol sets out to test whether dual-task training can improve self-efficacy, functional performance, and quality of life in people with Parkinson’s disease, while also probing whether the best training approach depends on cognitive status.
The trial is built around a practical clinical uncertainty: whether a motor-cognitive training program or a motor-motor program works better, and whether fixed attention instructions or variable attention instructions matter more for patients with and without cognitive impairment. The investigators are not treating dual-task interference as a simple nuisance variable. They are treating it as a measurable biological and behavioral problem that may shape mobility, confidence, and participation in daily life.
Parkinson’s disease weakens the ability to perform actions that healthy people usually carry out with little thought. Once a person must divide attention, gait speed, stride length, balance control, and even cognitive performance can deteriorate. In people with mild cognitive impairment, the interference appears even greater, and that may help explain why some patients avoid everyday dual-task situations such as walking while talking or managing a complex household task.
Why confidence may matter as much as performance
A major strength of this protocol is its focus on self-efficacy. In rehabilitation, confidence is not a soft outcome divorced from function; it can influence effort, persistence, and willingness to practice. Lower self-efficacy in Parkinson’s disease has been linked to worse motor and non-motor symptoms and poorer quality of life, while stronger perceived ability can reinforce engagement in therapy and improve task execution.
The protocol is built on that reciprocal loop. Better performance can raise confidence, and higher confidence can improve performance. In a disease where fear of falling, embarrassment during cognitively demanding tasks, and reduced social participation can restrict daily activity, that loop may be clinically meaningful even before any biomarker shifts are considered.
The investigators will also examine whether dual-task improvements correspond to changes in cortical activity, using functional Near-Infrared Spectroscopy to measure prefrontal cortex activation. That choice is biologically sensible. People with Parkinson’s disease often recruit extra prefrontal resources to compensate for impaired automatic movement. Higher activation during dual-tasking may therefore reflect greater effort, less efficient neural processing, or both.
Fixed and variable priorities will be tested inside a factorial design
The protocol uses a nested 2×2 factorial design within cognitive status. Participants will be randomized into one of four groups combining task type and priority instruction: motor-cognitive with fixed priority, motor-cognitive with variable priority, motor-motor with fixed priority, or motor-motor with variable priority. Cognitive impairment functions as a second layer of stratification, allowing the study to ask whether treatment response differs between those with and without cognitive decline.
Fixed-priority training asks participants to maintain attention on both tasks throughout the session. Variable-priority training shifts attention, with half the session focused on the motor task and the remainder on the secondary task. The contrast is more than procedural. It probes how the brain allocates scarce attention under training conditions that resemble, and may eventually improve, everyday life.
Each participant will complete 24 individual sessions over 8 weeks, with training delivered three times per week for 60 minutes per session. The sessions will be individualized by an interdisciplinary team, and the therapists delivering the intervention will be trained specifically for dual-task work. Baseline assessments will shape the intervention plan, which matters because dual-task failure in Parkinson’s disease is rarely one-size-fits-all.
Prefrontal activation may help explain who benefits
The protocol’s mechanistic ambition is as important as its rehabilitation focus. Dual-task cost is often treated as a behavioral endpoint, but this study explicitly asks whether changes in function and quality of life line up with changes in motor and cognitive performance, patient-reported outcomes, and prefrontal cortical activity. If a training modality reduces the need for excessive prefrontal recruitment while improving performance, that would support the idea that rehabilitation can enhance neural efficiency rather than simply teach compensatory effort.
fNIRS is especially well suited to this question because it can be used during task performance and has already shown feasibility and tolerability in Parkinson’s disease. The technology does not replace clinical outcomes, but it can help explain them. A reduction in prefrontal overactivation during dual-tasking would suggest less cognitive strain for the same or better movement output, a combination that could translate into safer mobility and more confidence outside the clinic.
This protocol also addresses a gap that has persisted in the literature: whether motor-cognitive dual-tasking is always the more difficult format, and whether greater interference predicts greater training benefit. Existing data suggest motor-cognitive tasks often create more interference than motor-motor tasks, but the most effective rehabilitation dose, task pairing, and instruction strategy remain unsettled.
Who enters the trial and how outcomes will be judged
Eligible participants have idiopathic Parkinson’s disease confirmed by a neurologist, with Hoehn and Yahr stages I to III. They must be able to walk independently and have stable medication dosing and type for up to three months before study entry. The protocol also allows enrollment of participants with no cognitive impairment and those with mild to moderate cognitive impairment, as well as participants with or without depression symptoms.
Exclusion criteria include other neurological or musculoskeletal disease, history of leg or brain trauma or surgery, and sensory limitations that would interfere with participation. Those criteria are consistent with the study’s goal of isolating the effects of dual-task training rather than confounding the results with unrelated mobility disorders.
Outcome measures include self-efficacy, motor and cognitive performance, quality of life, and prefrontal cortex activity. The protocol specifically names tools such as the General Self-Efficacy scale, the Self-Efficacy to Manage Chronic Disease scale, the Parkinson’s disease questionnaire, the Montreal Cognitive Assessment, and serial threes testing. All participants will be assessed at baseline and again after the 24-session program.
What this protocol can and cannot answer yet
Because this is a protocol, it offers no efficacy result, no responder analysis, and no safety signal. Its value lies in design: a randomized, blinded assessment framework with allocation concealment, individualized therapy planning, and a mechanistic readout beyond conventional clinical scales. The trial is registered as NCT07611578, and the investigators have set out to compare rehabilitation strategies that map closely onto the daily problems people with Parkinson’s disease actually face.
If the study shows that one combination of task type and attentional strategy improves function more than the others, clinicians may gain a more tailored way to prescribe dual-task rehabilitation. If prefrontal activation shifts in parallel with functional gains, the field will have a stronger biological explanation for why some training approaches work better than others. Until the outcomes are reported, the protocol stands as a carefully structured attempt to turn a common bedside observation—difficulty handling two things at once—into a testable rehabilitation strategy.